Overview

A world-class team of research institutions focused on finding a cure for prostate cancer

The Pacific Northwest Prostate Cancer SPORE is a group of four prominent research institutions working together toward a common goal of eradicating prostate cancer. This work begins with gaining a better understanding of this disease.

Specialized Programs of Research Excellence (SPORE) … promoting interdisciplinary research and moving basic research findings from the laboratory to clinical settings…


2002:
NCI awards Fred Hutchinson Cancer Research Center $12.7 million to lead a multi-center, multi-project, five-year investigation into the genetic mechanisms of prostate cancer progression. Understanding how and why prostate cancer can turn deadly is key to developing therapies that may effectively treat men with recurrent or advanced prostate cancer, for which there is no cure. Under the direction of Principal Investigator (PI) Paul Lange, MD, and co-PIs Janet Stanford, PhD, and Peter Nelson, MD, the initiative involved more than 50 investigators from four institutions in Seattle and Vancouver, BC.

2006: NCI renews the PNW Prostate Cancer SPORE grant under the direction of Dr. Peter Nelson, PI, and co-PIs, Drs. Janet Stanford and Paul Lange. A new five-year, $11.8 million grant was awarded to further the PNW SPORE’s aim to address fundamental questions underlying prostate cancer risk, prognosis, and therapeutic response, reinforcing the reputation of the Pacific Northwest consortium as a major force in prostate cancer research.

2013: The PNW Prostate Cancer SPORE is awarded an $11.3 million, five-year competitive grant renewal for its continued leadership of a multi-center prostate cancer research consortium whose collective goal is to reduce the morbidity and mortality associated with prostate cancer. This continuation represents a coordinated effort between four institutions, each with established programs and strengths in translational prostate cancer research.